Replacement of the systemic tricuspid valve in a patient with corrected transposition of the great arteries, ventricular septal defect, and Eisenmenger syndrome

对一名患有矫正型大动脉转位、室间隔缺损和艾森门格综合征的患者进行系统性三尖瓣置换术

阅读:1

Abstract

This case report presents a 56-year-old female patient with Eisenmenger syndrome. The diagnosis of corrected transposition of the great arteries with ventricular septal defect (VSD) was established in 1994. Worsening of condition occurred in 2015 and was related to the severe regurgitation on the systemic morphologically tricuspid valve. The main complaints at admission to the Bakoulev Scientific Center for Cardiovascular Surgery in 2017 included fatigue and dyspnea at rest or minimal exercise. The patient was on disability and receiving diuretics. Her condition was considered New York Heart Association (NYHA) class IV. The systemic tricuspid valve demonstrated dilated fibrous annulus as well as thickened and prolapsed leaflets with regurgitation of 3-4 degree. Since regurgitation on the systemic tricuspid valve was considered the main cause of heart failure in the patient with Eisenmenger syndrome, the valve was replaced with the CarboMedics 28-mm mechanical prosthesis, with the VSD left intact. The postoperative period was uneventful. Five and half years after surgery, the patient was in NYHA class II on a specific pulmonary arterial hypertension therapy with no signs of heart failure. The function of the mechanical valve was adequate. Thus, the replacement of the systemic tricuspid valve helped eliminate heart failure and achieve compensation on a specific pulmonary arterial hypertension therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12055-024-01802-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。